{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:28:00Z","timestamp":1776504480222,"version":"3.51.2"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0023120","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T21:03:20Z","timestamp":1312232600000},"page":"e23120","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Antimonial Resistance in Leishmania donovani Is Associated with Increased In Vivo Parasite Burden"],"prefix":"10.1371","volume":"6","author":[{"given":"Manu","family":"Vanaerschot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simonne","family":"De Doncker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman","family":"Rijal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Maes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Dujardin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saskia","family":"Decuypere","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2011,8,1]]},"reference":[{"key":"ref1","article-title":"World health report, 2002: reducing risks, promoting healthy life - annex 3: burden of disease in DALYs by cause, sex and mortality stratum in WHO regions, estimates for 2001","year":"2002"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrmicro1748","article-title":"Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?","volume":"5","author":"F Chappuis","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1086\/314896","article-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of <italic>Leishmania donovani<\/italic>.","volume":"180","author":"R Lira","year":"1999","journal-title":"J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.micinf.2007.01.009","article-title":"Antimonial treatment of visceral leishmaniasis: are current <italic>in vitro<\/italic> susceptibility assays adequate for prognosis of <italic>in vivo<\/italic> therapy outcome?","volume":"9","author":"S Rijal","year":"2007","journal-title":"Microbes Infect"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","article-title":"Molecular mechanisms of antimony resistance in <italic>Leishmania<\/italic>.","volume":"56","author":"Ashutosh","year":"2007","journal-title":"J Med Microbiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/CMR.19.1.111-126.2006","article-title":"Drug resistance in leishmaniasis.","volume":"19","author":"SL Croft","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/j.1432-1033.1995.tb20583.x","article-title":"Trypanothione reductase from <italic>Leishmania donovani<\/italic>. Purification, characterisation and inhibition by trivalent antimonials.","volume":"230","author":"ML Cunningham","year":"1995","journal-title":"Eur J Biochem"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.50.5.1788-1797.2006","article-title":"Sodium antimony gluconate induces generation of reactive oxygen species and nitric oxide via phosphoinositide 3-kinase and mitogen-activated protein kinase activation in <italic>Leishmania donovani<\/italic>-infected macrophages.","volume":"50","author":"BJ Mookerjee","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"39925","DOI":"10.1074\/jbc.M405635200","article-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen <italic>Leishmania donovani<\/italic>.","volume":"279","author":"S Wyllie","year":"2004","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e12211","DOI":"10.1371\/journal.pone.0012211","article-title":"Linking <italic>in vitro<\/italic> and <italic>in vivo<\/italic> survival of clinical <italic>Leishmania donovani<\/italic> strains.","volume":"5","author":"M Vanaerschot","year":"2010","journal-title":"PLoS ONE"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1086\/382049","article-title":"Antigen genes for molecular epidemiology of leishmaniasis: polymorphism of cysteine proteinase B and surface metalloprotease glycoprotein 63 in the <italic>Leishmania donovani<\/italic> complex.","volume":"189","author":"KW Quispe Tintaya","year":"2004","journal-title":"J Infect Dis"},{"key":"ref12","first-page":"1","article-title":"Antigenic variation in syringe passaged populations of <italic>Trypanosoma<\/italic> (Trypanozoon) <italic>brucei<\/italic>. 1. Rationalization of the experimental approach.","volume":"55","author":"N Van Meirvenne","year":"1975","journal-title":"Ann Soc Belg Med Trop"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijantimicag.2007.05.007","article-title":"Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage of Leishmania donovani and persists in vivo.","volume":"30","author":"K Seifert","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"R19","DOI":"10.1186\/gb-2007-8-2-r19","article-title":"qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data.","volume":"8","author":"J Hellemans","year":"2007","journal-title":"Genome Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0035-9203(03)90071-X","article-title":"Skewing of cytokine profiles towards T helper cell type 2 response in visceral leishmaniasis patients unresponsive to sodium antimony gluconate.","volume":"97","author":"CP Thakur","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref16","article-title":"Increased metacyclogenesis of antimony-resistant <italic>Leishmania donovani<\/italic> clinical lines.","author":"M Ouakad","year":"2011"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"e1000907","DOI":"10.1371\/journal.ppat.1000907","article-title":"<italic>Leishmania donovani<\/italic> isolates with antimony-resistant but not -sensitive phenotype inhibit sodium antimony gluconate-induced dendritic cell activation.","volume":"6","author":"AK Haldar","year":"2010","journal-title":"PLoS Pathog"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1128\/AAC.41.9.1898","article-title":"In vitro life cycle of pentamidine-resistant amastigotes: stability of the chemoresistant phenotypes is dependent on the level of resistance induced.","volume":"41","author":"D Sereno","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1017\/S0031182004005098","article-title":"Cell differentiation and infectivity of Leishmania mexicana are inhibited in a strain resistant to an ABC-transporter blocker.","volume":"128","author":"N Silva","year":"2004","journal-title":"Parasitology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4616","DOI":"10.1128\/AAC.49.11.4616-4621.2005","article-title":"Gene expression analysis of the mechanism of natural Sb(V) resistance in Leishmania donovani isolates from Nepal.","volume":"49","author":"S Decuypere","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4269\/ajtmh.2005.73.272","article-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine.","volume":"73","author":"V Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1056\/NEJM199912093412403","article-title":"Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.","volume":"341","author":"TK Jha","year":"1999","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01233-08","article-title":"<italic>In vitro<\/italic> susceptibility of field isolates of <italic>Leishmania donovani<\/italic> to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity.","volume":"53","author":"D Kumar","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1128\/AAC.47.8.2397-2403.2003","article-title":"Leishmania donovani resistance to miltefosine involves a defective inward translocation of the drug.","volume":"47","author":"FJ Perez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.drup.2006.04.001","article-title":"Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.","volume":"9","author":"FJ Perez-Victoria","year":"2006","journal-title":"Drug Resist Updat"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S0924-8579(03)00125-0","article-title":"Characterisation of Leishmania donovani promastigotes resistant to hexadecylphosphocholine (miltefosine).","volume":"22","author":"K Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(10)62050-8","article-title":"Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial.","volume":"377","author":"S Sundar","year":"2011","journal-title":"Lancet"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0023120","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T14:51:04Z","timestamp":1589035864000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0023120"}},"subtitle":[],"editor":[{"given":"Mauricio Martins","family":"Rodrigues","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2011,8,1]]},"references-count":27,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0023120","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,1]]}}}